P2Y receptors regulate proliferation of human pancreatic duct epithelial cells
- PMID: 22249129
- DOI: 10.1097/MPA.0b013e31823ba3b3
P2Y receptors regulate proliferation of human pancreatic duct epithelial cells
Abstract
Objectives: The aim of this study was to investigate the effect of P2Y receptor activation on proliferation of human pancreatic duct epithelial cells.
Methods: Proliferation was measured by immunoassay for bromodeoxyuridine incorporation into a pancreatic duct epithelial cell line, PANC-1. Expression of P2Y receptors was examined using quantitative reverse transcription-polymerase chain reaction and Western blot.
Results: Extracellular nucleotides, adenosine diphosphate (ADP) and uridine diphosphate (UDP), stimulated proliferation of pancreatic duct cells in a concentration-dependent manner. The nucleotide efficacy order was ADP > UDP > uridine triphosphate (UTP) > adenosine triphosphate. P2Y(1) and P2Y(6) receptor blockers, MRS2500 and MRS2578, blocked the effect of ADP and UDP. The signal that transmitted the proliferative activity of ADP and UDP was transducted to phospholipase C, inositol 1,4,5-triphosphate receptor, and protein kinase C. These results indicate involvement of P2Y(1) and P2Y(6) receptors in ADP- and UDP-stimulated proliferation. Pancreatic duct cells expressed the messenger RNA transcripts of P2Y receptors, P2Y(1) , P2Y(2), and P2Y(6), and P2Y(1) and P2Y(6) receptor protein.
Conclusions: Extracellular nucleotides increase proliferation of human pancreatic duct epithelial cells by activation of P2Y(1) and P2Y(6) receptors. This provides the basic model for the effect of P2Y receptors on the proliferation of pancreatic duct epithelial cells.
Similar articles
-
Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor.Pancreas. 2013 May;42(4):680-6. doi: 10.1097/MPA.0b013e318271bb4b. Pancreas. 2013. PMID: 23462325
-
Cellular injury induces activation of MAPK via P2Y receptors.J Cell Biochem. 2004 Apr 1;91(5):938-50. doi: 10.1002/jcb.10774. J Cell Biochem. 2004. PMID: 15034929
-
Osteoblast responses to nucleotides increase during differentiation.Bone. 2006 Aug;39(2):300-9. doi: 10.1016/j.bone.2006.02.063. Epub 2006 Apr 17. Bone. 2006. PMID: 16616882
-
Identification of the P2Y(12) receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides.Mol Pharmacol. 2001 Sep;60(3):416-20. Mol Pharmacol. 2001. PMID: 11502870 Review. No abstract available.
-
Signalling and pharmacological properties of the P2Y receptor.Acta Physiol (Oxf). 2010 Jun;199(2):149-60. doi: 10.1111/j.1748-1716.2010.02116.x. Epub 2010 Mar 24. Acta Physiol (Oxf). 2010. PMID: 20345417 Free PMC article. Review.
Cited by
-
Reviewing the role of P2Y receptors in specific gastrointestinal cancers.Purinergic Signal. 2019 Dec;15(4):451-463. doi: 10.1007/s11302-019-09678-x. Epub 2019 Sep 2. Purinergic Signal. 2019. PMID: 31478181 Free PMC article.
-
Anti-proliferative Effects of Nucleotides on Gastric Cancer via a Novel P2Y6/SOCE/Ca2+/β-catenin Pathway.Sci Rep. 2017 May 26;7(1):2459. doi: 10.1038/s41598-017-02562-x. Sci Rep. 2017. PMID: 28550303 Free PMC article.
-
The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance.Cancers (Basel). 2017 Oct 24;9(10):142. doi: 10.3390/cancers9100142. Cancers (Basel). 2017. PMID: 29064388 Free PMC article.
-
Physiological impact of abnormal lipoxin A₄ production on cystic fibrosis airway epithelium and therapeutic potential.Biomed Res Int. 2015;2015:781087. doi: 10.1155/2015/781087. Epub 2015 Mar 19. Biomed Res Int. 2015. PMID: 25866809 Free PMC article. Review.
-
Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion.Elife. 2023 Mar 21;12:e86971. doi: 10.7554/eLife.86971. Elife. 2023. PMID: 36942939 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources